Lakefront Biotherapeutics NV
LKFT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001421876
No open-market purchases or sales by Lakefront Biotherapeutics NV insiders were filed in the last 90 days; 76 institutions reported holding it in 13F filings for Q2 2026, worth $960.3M in total; Greenlight Capital is the only superinvestor holding it.
Other share classesGLPGF
Q2 2025 vs. Q1 2025
How the institutions holding Lakefront Biotherapeutics NV changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Of which not filed for Q2 2025 | Q2 2025 | Change |
|---|---|---|---|---|
| Holders | 83 | 1 | 85 | +3 |
| Shares | 31.2M | 131 | 31.7M | +507.6K (+1.6%) |
| Value | $783.2M | $3.29K | $887.2M | +$104.0M (+13.3%) |
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Lakefront Biotherapeutics NV at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Madison Avenue Partners, LP | 1,877,011 | $52.5M | 3.51% |
| Point72 Asset Management, L.P. | 341,500 | $9.56M | 0.02% |
| Voloridge Investment Management, LLC | 85,401 | $2.39M | 0.01% |
| Goldman Sachs Group Inc | 56,731 | $1.59M | 0.00% |
| XTX Topco Ltd | 39,803 | $1.11M | 0.05% |
| Jump Financial, LLC | 24,730 | $692.2K | 0.01% |
| Boothbay Fund Management, LLC | 21,866 | $612.0K | 0.02% |
| Engineers Gate Manager LP | 19,990 | $559.5K | 0.01% |
| Cubist Systematic Strategies, LLC | 12,371 | $346.3K | 0.00% |
| Citadel Advisors LLC | 11,707 | $327.7K | 0.00% |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Management | 9,312 | $260.6K | 0.01% |
| Graham Capital Management, L.P. | 8,538 | $239.0K | 0.01% |
| Clear Street Markets LLC | 8,234 | $230.5K | 0.08% |
| Headlands Technologies LLC | 7,973 | $223.2K | 0.03% |
| Geode Capital Management, LLC | 7,851 | $219.7K | 0.00% |
| State of Wyoming | 1,018 | $28.5K | 0.00% |
| EverSource Wealth Advisors, LLC | 408 | $11.4K | 0.00% |
| Larson Financial Group LLC | 60 | $1.68K | 0.00% |
| MAI Capital Management | 52 | $1.46K | 0.00% |
| TD Private Client Wealth LLC | 24 | $672 | 0.00% |
| Assetmark, Inc | 12 | $336 | 0.00% |
Sold out (18)
Institutions that held Lakefront Biotherapeutics NV at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| BVF Inc | 1,454,422 | $36.5M |
| Deep Track Capital, LP | 741,068 | $18.6M |
| Finepoint Capital LP | 656,587 | $16.5M |
| Newtyn Management, LLC | 200,000 | $5.02M |
| Vestal Point Capital, LP | 200,000 | $5.02M |
| 683 Capital Management, LLC | 110,100 | $2.77M |
| Stonepine Capital Management, LLC | 93,968 | $2.36M |
| J. Goldman & Co LP | 84,307 | $2.12M |
| Old Mission Capital LLC | 75,043 | $1.89M |
| Tejara Capital Ltd | 53,786 | $1.35M |
| Abc Arbitrage SA | 13,241 | $332.6K |
| Squarepoint Ops LLC | 8,154 | $204.8K |
| Quadrant Capital Group LLC | 4,429 | $111.3K |
| Group One Trading, L.P. | 3,135 | $78.8K |
| Simplex Trading, LLC | 1,724 | $43.0K |
| JPMorgan Chase & Co | 835 | $21.0K |
| Hexagon Capital Partners LLC | 133 | $3.34K |
| Skopos Labs, Inc. | 74 | $1.86K |
Not filed for Q2 2025 yet (1)
Institutions that held Lakefront Biotherapeutics NV at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Lindbrook Capital, LLC | 131 | $3.29K |